Jan. 4, 2024, 8:30 a.m. | Business Wire

AI – AI-TechPark ai-techpark.com

Recognition Highlights Dedication to Innovation and the Transformative Impact of AI-driven Solutions to Advance Drug Development BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, today announced that it has been named a leading innovator in AI drug repurposing in a recent report published in Pharmaceutical Technology, part...


The post BostonGene named Leading Innovator in AI-Driven Drug Repurposing first appeared on AI-TechPark.

advance dedication development drug development highlights impact innovation machine learning part pharmaceutical profiling provider recognition report solutions technology

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US